Evidence map›Paper›PMID 20211158›Full record

ReviewChemico-biological interactions2010

Review of tyrosine and lysine as new motifs for organophosphate binding to proteins that have no active site serine.

Oksana Lockridge, Lawrence M Schopfer

Abstract readReview
In one paragraph

Review in Chemico-biological interactions, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Organophosphorus Pesticides Promote Protein Cross-Linking.Chemical research in toxicology · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Polyclonal antibody to soman-tyrosine.Chemical research in toxicology · 2013
    Article
  18. Immunodetection of serum albumin adducts as biomarkers for organophosphorus exposure.The Journal of pharmacology and experimental therapeutics · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Oksana LockridgeEppley Institute, 985950 University of Nebraska Medical Center, Omaha, NE 68198-5950, United States. olockrid@unmc.edu
Lawrence M Schopfer
Nebraska Medical Center · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Apar Kishor Ganti · 1985 to 2026
$55.0M
Mass Spectrometry in Clinical Diagnosis of Nerve Agent ExposureU01NS058056 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LOCKRIDGE, OKSANA · 2006 to 2008
$1.4M
NCI NIH HHS P30 CA036727NCI NIH HHS P30CA36727NINDS NIH HHS U01 NS058056
6 · The paper itself

Abstract

The accepted target for organophosphorus agent (OP) binding to enzymes is the active site serine in the consensus sequence Gly X Ser X Gly. New motifs have been identified by using mass spectrometry to fragment OP-labeled peptides. It has been found that OP can make covalent bonds with tyrosine and lysine in proteins that have no active site serine. The OP-tyrosine bond is stable, and does not undergo the decay seen with OP-serine. Information on OP binding to tyrosine has been applied to diagnosis of OP exposure, through the use of mass spectrometry to detect OP-labeled albumin in human and animal plasma. It is expected that the new OP binding motif will aid in the search for a mechanism of low dose OP toxicity. It is hypothesized that proteins involved in axonal transport, especially proteins whose function depends on reversible phosphorylation, are prime candidates for a role in OP-induced neurodegeneration. Treatment of neurodegenerative disorders could be developed by identifying methods to reverse OP binding to tyrosine.

Indexed as

Catalytic DomainAnimalsHumansHydrolasesLysineOrganophosphatesProtein BindingTyrosineHydrolasesLysineOrganophosphatesTyrosine

Identifiers

PMID20211158
PMCPMC2905678
OpenAlexW2058088418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.